122 related articles for article (PubMed ID: 19237835)
1. [Clinical characteristics and malignant predictive factors of pancreatic neuroendocrine tumors].
Han JH; Kim MH; Moon SH; Park SJ; Park DH; Lee SS; Seo DW; Lee SK; Kim SC; Han DJ
Korean J Gastroenterol; 2009 Feb; 53(2):98-105. PubMed ID: 19237835
[TBL] [Abstract][Full Text] [Related]
2. Analysis of risk factors for recurrence after curative resection of well-differentiated pancreatic neuroendocrine tumors based on the new grading classification.
Tsutsumi K; Ohtsuka T; Fujino M; Nakashima H; Aishima S; Ueda J; Takahata S; Nakamura M; Oda Y; Tanaka M
J Hepatobiliary Pancreat Sci; 2014 Jun; 21(6):418-25. PubMed ID: 24142395
[TBL] [Abstract][Full Text] [Related]
3. Morbidity and mortality of aggressive resection in patients with advanced neuroendocrine tumors.
Norton JA; Kivlen M; Li M; Schneider D; Chuter T; Jensen RT
Arch Surg; 2003 Aug; 138(8):859-66. PubMed ID: 12912744
[TBL] [Abstract][Full Text] [Related]
4. Surgical experience with nonfunctioning neuroendocrine tumors of the pancreas.
Matthews BD; Heniford BT; Reardon PR; Brunicardi FC; Greene FL
Am Surg; 2000 Dec; 66(12):1116-22; discussion 1122-3. PubMed ID: 11149582
[TBL] [Abstract][Full Text] [Related]
5. [Clinicopathological features and multivariate analysis of prognostic factors for patients with gastroenteropancreatic neuroendocrine tumors].
Wang X; Song ZF; Yao WX; Pan CC; Xiang MF; Wang H
Zhonghua Yi Xue Za Zhi; 2013 May; 93(18):1411-4. PubMed ID: 24025507
[TBL] [Abstract][Full Text] [Related]
6. Malignant-functioning neuroendocrine tumors of the pancreas: A survival analysis.
Keutgen XM; Nilubol N; Kebebew E
Surgery; 2016 May; 159(5):1382-9. PubMed ID: 26704781
[TBL] [Abstract][Full Text] [Related]
7. [Hormone inactive neuroendocrine tumors of the pancreas].
Schwab M; Knoll MR; Jentschura D; Hagmüller E
Chirurg; 1997 Jul; 68(7):705-9. PubMed ID: 9340236
[TBL] [Abstract][Full Text] [Related]
8. Resection of pancreatic neuroendocrine tumors: results of 70 cases.
Kazanjian KK; Reber HA; Hines OJ
Arch Surg; 2006 Aug; 141(8):765-9; discussion 769-70. PubMed ID: 16924083
[TBL] [Abstract][Full Text] [Related]
9. [Clinical features of neuroendocrine tumor of the pancreas: single center study].
Kang TW; Lee KT; Ryu MK; Moon W; Lee SS; Lee SY; Hwang JY; Lee JK; Heo JS; Choi SH; Kim SH; Paik SW; Rhee JC
Korean J Gastroenterol; 2006 Aug; 48(2):112-8. PubMed ID: 16929155
[TBL] [Abstract][Full Text] [Related]
10. Nonfunctioning neuroendocrine pancreatic tumors: our experience and management.
Nomura N; Fujii T; Kanazumi N; Takeda S; Nomoto S; Kasuya H; Sugimoto H; Yamada S; Nakao A
J Hepatobiliary Pancreat Surg; 2009; 16(5):639-47. PubMed ID: 19365596
[TBL] [Abstract][Full Text] [Related]
11. Nonfunctioning neuroendocrine tumors of the pancreas: clinical presentation of 7 patients.
Closset J; Delhaye M; Sperduto N; Rickaert F; Gelin M
Hepatogastroenterology; 1996; 43(12):1640-4. PubMed ID: 8975980
[TBL] [Abstract][Full Text] [Related]
12. Predicting aggressive behavior in nonfunctioning pancreatic neuroendocrine tumors.
Cherenfant J; Stocker SJ; Gage MK; Du H; Thurow TA; Odeleye M; Schimpke SW; Kaul KL; Hall CR; Lamzabi I; Gattuso P; Winchester DJ; Marsh RW; Roggin KK; Bentrem DJ; Baker MS; Prinz RA; Talamonti MS
Surgery; 2013 Oct; 154(4):785-91; discussion 791-3. PubMed ID: 24074416
[TBL] [Abstract][Full Text] [Related]
13. Neuroendocrine tumors of the pancreas: Degree of cystic component predicts prognosis.
Cloyd JM; Kopecky KE; Norton JA; Kunz PL; Fisher GA; Visser BC; Dua MM; Park WG; Poultsides GA
Surgery; 2016 Sep; 160(3):708-13. PubMed ID: 27216830
[TBL] [Abstract][Full Text] [Related]
14. [Operative management and long-term survival in patients with neuroendocrine tumors of the pancreas--experience with 144 patients].
Fendrich V; Habbe N; Celik I; Langer P; Zielke A; Bartsch DK; Rothmund M
Dtsch Med Wochenschr; 2007 Feb; 132(5):195-200. PubMed ID: 17252361
[TBL] [Abstract][Full Text] [Related]
15. Surgical experience with pancreatic and peripancreatic neuroendocrine tumors: review of 125 patients.
Phan GQ; Yeo CJ; Hruban RH; Lillemoe KD; Pitt HA; Cameron JL
J Gastrointest Surg; 1998; 2(5):472-82. PubMed ID: 9843608
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic neuroendocrine tumor: A multivariate analysis of factors influencing survival.
Birnbaum DJ; Turrini O; Ewald J; Barbier L; Autret A; Hardwigsen J; Brunet C; Moutardier V; Le Treut YP; Delpero JR
Eur J Surg Oncol; 2014 Nov; 40(11):1564-71. PubMed ID: 25086992
[TBL] [Abstract][Full Text] [Related]
17. Neuroendocrine tumors of the pancreas.
Varshney S; Johnson CD
Indian J Gastroenterol; 2000; 19(4):181-3. PubMed ID: 11059186
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine tumors of the pancreas: a retrospective single-center analysis using the ENETS TNM-classification and immunohistochemical markers for risk stratification.
Brunner SM; Weber F; Werner JM; Agha A; Farkas SA; Schlitt HJ; Hornung M
BMC Surg; 2015 Apr; 15():49. PubMed ID: 25928025
[TBL] [Abstract][Full Text] [Related]
19. Intraductal papillary or mucinous tumors (IPMT) of the pancreas: report of a case series and review of the literature.
Zamora C; Sahel J; Cantu DG; Heyries L; Bernard JP; Bastid C; Payan MJ; Sielezneff I; Familiari L; Sastre B; Barthet M
Am J Gastroenterol; 2001 May; 96(5):1441-7. PubMed ID: 11374680
[TBL] [Abstract][Full Text] [Related]
20. Surgical strategies and predictors of outcome for malignant neuroendocrine tumors of the pancreas.
Bahra M; Jacob D; Pascher A; Plockinger U; Kristiansen G; Neuhaus P; Langrehr JM
J Gastroenterol Hepatol; 2007 Jun; 22(6):930-5. PubMed ID: 17489964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]